Insider Transactions Reported by 15 Insiders of Contineum Therapeutics, Inc.

Symbol
CTNM on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

Contineum Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
JOHNSON & JOHNSON 10%+ Owner $33,744,900 09 Apr 2024
Versant Venture Capital VI, L.P. 10%+ Owner $8,931,592 09 Apr 2024
Daniel S. Lorrain Chief Scientific Officer $2,365,919 -$357,607 -13% 02 Mar 2026
Carmine N. Stengone CEO and President, Director $239,495 -$120,128 -33% 24 Feb 2026
Stephen L. Huhn CMO & Sr VP, Clinical Dev. $218,240 31 Jan 2025
Tim Watkins CMO & Head of Development $0 -$148,967 -100% 02 Mar 2026
Olivia C. Ware Director 26 Jun 2025
John Stephen Healy General Counsel and Corp Sec 30 Jan 2026
Sarah Boyce Director 26 Jun 2025
Gines Diego Miralles Director 26 Jun 2025
Troy A. Ignelzi Director 26 Jun 2025
Todd R. Brady Director 26 Jun 2025
Slover Peter T. Chief Financial Officer 30 Jan 2026
Lori Lyons-Williams Director 26 Jun 2025
Evert B. Schimmelpennink Director 26 Jun 2025

Recent Insider Transactions by Companies or Individuals for Contineum Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Daniel S. Lorrain CTNM Class A Common Stock Sale -2.67% $62,585 $15.01 -4,170 151,882 02 Mar 2026 Direct
Tim Watkins CTNM Class A Common Stock Sale -100% $54,220 $15.02 -3,611 0 02 Mar 2026 Direct
Tim Watkins CTNM Class A Common Stock Options Exercise 3,611 3,611 02 Mar 2026 Direct
Tim Watkins CTNM Stock Option (right to buy) Options Exercise -1.43% -3,611 249,167 02 Mar 2026 Direct
Carmine N. Stengone CTNM Class A Common Stock Sale -15.3% $43,242 $16.02 -2,700 14,954 25 Feb 2026 Direct
Carmine N. Stengone CTNM Class A Common Stock Options Exercise 18.1% 2,700 17,654 25 Feb 2026 Direct
Carmine N. Stengone CTNM Stock Option (right to buy) Options Exercise -2.18% -2,700 120,917 25 Feb 2026 Direct
Daniel S. Lorrain CTNM Class A Common Stock Sale -2.39% $61,228 $16.01 -3,824 156,052 25 Feb 2026 Direct
Daniel S. Lorrain CTNM Class A Common Stock Options Exercise 2.45% 3,824 159,876 25 Feb 2026 Direct
Daniel S. Lorrain CTNM Stock Option (right to buy) Options Exercise -5.38% -3,824 67,306 25 Feb 2026 Direct
Carmine N. Stengone CTNM Class A Common Stock Sale -22.7% $70,486 $16.02 -4,400 14,954 24 Feb 2026 Direct
Carmine N. Stengone CTNM Class A Common Stock Options Exercise 29.4% 4,400 19,354 24 Feb 2026 Direct
Carmine N. Stengone CTNM Stock Option (right to buy) Options Exercise -3.44% -4,400 123,617 24 Feb 2026 Direct
Daniel S. Lorrain CTNM Class A Common Stock Sale -2.68% $68,936 $16.03 -4,300 156,052 24 Feb 2026 Direct
Daniel S. Lorrain CTNM Class A Common Stock Options Exercise 2.76% 4,300 160,352 24 Feb 2026 Direct
Daniel S. Lorrain CTNM Stock Option (right to buy) Options Exercise -5.7% -4,300 71,130 24 Feb 2026 Direct
Daniel S. Lorrain CTNM Class A Common Stock Sale -0.06% $1,600 $16.00 -100 156,052 19 Feb 2026 Direct
Daniel S. Lorrain CTNM Class A Common Stock Options Exercise 0.06% 100 156,152 19 Feb 2026 Direct
Daniel S. Lorrain CTNM Stock Option (right to buy) Options Exercise -0.13% -100 75,430 19 Feb 2026 Direct
Carmine N. Stengone CTNM Class A Common Stock Sale -2.61% $6,400 $16.00 -400 14,954 11 Feb 2026 Direct
Carmine N. Stengone CTNM Class A Common Stock Options Exercise 2.67% 400 15,354 11 Feb 2026 Direct
Carmine N. Stengone CTNM Stock Option (right to buy) Options Exercise -0.31% -400 128,017 11 Feb 2026 Direct
Daniel S. Lorrain CTNM Class A Common Stock Sale -0.26% $6,400 $16.00 -400 156,052 11 Feb 2026 Direct
Daniel S. Lorrain CTNM Class A Common Stock Options Exercise 0.26% 400 156,452 11 Feb 2026 Direct
Daniel S. Lorrain CTNM Stock Option (right to buy) Options Exercise -0.53% -400 75,530 11 Feb 2026 Direct
Daniel S. Lorrain CTNM Class A Common Stock Sale -2.6% $62,305 $14.94 -4,170 156,052 03 Feb 2026 Direct
John Stephen Healy CTNM Stock Option (right to buy) Award 206,411 206,411 30 Jan 2026 Direct
Carmine N. Stengone CTNM Stock Option (right to buy) Award 445,000 445,000 30 Jan 2026 Direct
Daniel S. Lorrain CTNM Stock Option (right to buy) Award 6,500 6,500 30 Jan 2026 By Spouse
Daniel S. Lorrain CTNM Stock Option (right to buy) Award 160,000 160,000 30 Jan 2026 Direct
Tim Watkins CTNM Stock Option (right to buy) Award 160,000 160,000 30 Jan 2026 Direct
Slover Peter T. CTNM Stock Option (right to buy) Award 192,000 192,000 30 Jan 2026 Direct
Tim Watkins CTNM Class A Common Stock Sale -100% $51,188 $14.18 -3,611 0 28 Jan 2026 Direct
Tim Watkins CTNM Class A Common Stock Options Exercise 3,611 3,611 28 Jan 2026 Direct
Tim Watkins CTNM Stock Option (right to buy) Options Exercise -1.41% -3,611 252,778 28 Jan 2026 Direct
Daniel S. Lorrain CTNM Class A Common Stock Sale -2.54% $43,543 $10.44 -4,170 160,222 05 Jan 2026 Direct
Tim Watkins CTNM Class A Common Stock Sale -100% $43,558 $12.06 -3,611 0 29 Dec 2025 Direct
Tim Watkins CTNM Class A Common Stock Options Exercise 3,611 3,611 29 Dec 2025 Direct
Tim Watkins CTNM Stock Option (right to buy) Options Exercise -1.39% -3,611 256,389 29 Dec 2025 Direct
Daniel S. Lorrain CTNM Class A Common Stock Sale -2.47% $51,009 $12.23 -4,170 164,392 23 Dec 2025 Direct
Sarah Boyce CTNM Stock Option (right to buy) Award 14,750 14,750 26 Jun 2025 Direct
Evert B. Schimmelpennink CTNM Stock Option (right to buy) Award 14,750 14,750 26 Jun 2025 Direct
Todd R. Brady CTNM Stock Option (right to buy) Award 14,750 14,750 26 Jun 2025 Direct
Troy A. Ignelzi CTNM Stock Option (right to buy) Award 14,750 14,750 26 Jun 2025 Direct
Lori Lyons-Williams CTNM Stock Option (right to buy) Award 14,750 14,750 26 Jun 2025 Direct
Olivia C. Ware CTNM Stock Option (right to buy) Award 14,750 14,750 26 Jun 2025 Direct
Gines Diego Miralles CTNM Stock Option (right to buy) Award 14,750 14,750 26 Jun 2025 Direct
Tim Watkins CTNM Stock Option (right to buy) Award 286,000 260,000 28 Apr 2025 Direct
Gines Diego Miralles CTNM Stock Option (right to buy) Award 29,500 29,500 14 Mar 2025 Direct
John Stephen Healy CTNM Stock Option (right to buy) Award 63,589 63,589 31 Jan 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.